Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS

João Cerqueira; Achim Berthele; Bruce Cree; Massimo Filippi; Gabriel Pardo; Owen Pearson; Anthony Traboulsee; Tjalf Ziemssen; Timothy Vollmer; Corrado Bernasconi; Corey R. Mandel; Inessa Kulyk; Cathy Chognot; Catarina Raposo; Hans‐Martin Schneble; Gian‐Andrea Thanei; Elodie Incera; Eva Havrdová

doi:10.1212/wnl.0000000000210142

Related publications

Article2023

Long-Term Treatment With First-Line Ocrelizumab in Patients With Early RMS: 9-Year OPERA Subgroup Analysis (S46.002)

João Cerqueira, Achim Berthele, Bruce Cree, Massimo Filippi, Gabriel Pardo, Owen Pearson, Anthony Traboulsee, Tjalf Ziemssen, Timothy Vollmer, Corrado Bernasconi, Corey R. Mandel, Inessa Kulyk, Cathy Chognot, Hans‐Martin Schneble, Kalpesh Prajapati, Eva Havrdová

Article2025

Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion

Paolo Preziosa, Vincenzo Brescia Morra, Marco Capobianco, Claudio Gasperini, Luigi Maria Edoardo Grimaldi, Girolama Alessandra Marfia, Damiano Paolicelli, Paola Perini, Valentina Torri Clerici, Massimo Filippi

Article2024

Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy

Massimo Filippi, Laura Ferrè, Chiara Zanetta, Caterina Rizzi, Gabriella Pessina, Francesco Assogna, Maria A. Rocca

Article2024

Updated Study Data for Ozanimod in Relapsing Multiple Sclerosis

John DeLuca, Massimo Filippi, Ralf Gold, Krzysztof Selmaj, Robert Zivanidov

Dataset

Supplementary Material for: Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

Clarence Yen, Ratnadeep Sharma, Lorenza Rimassa, T. Arizumi, D. Bettinger, Huay Yee Choo, Tiziana Pressiani, M.E. Burlone, M. Pirisi, Laura Giordano, Abdulkarim Abdulrahman, Masatoshi Kudo, Robert Thimme, J.W. Park, David J. Pinato